Lipid mediator class switching during acute inflammation: signals in resolution
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Leukotrienes (LTs) and prostaglandins (PGs) amplify acute inflammation, whereas lipoxins (LXs) have unique anti-inflammatory actions. Temporal analyses of these eicosanoids in clinical and experimental exudates showed early coordinate appearance of LT and PG with polymorphonuclear neutrophil (PMN) recruitment. This was followed by LX biosynthesis, which was concurrent with spontaneous resolution. Human peripheral blood PMNs exposed to PGE2 (as in exudates) switched eicosanoid biosynthesis from predominantly LTB4 and 5-lipoxygenase (5-LO)-initiated pathways to LXA4, a 15-LO product that "stopped" PMN infiltration. These results indicate that first-phase eicosanoids promote a shift to anti-inflammatory lipids: functionally distinct lipid-mediator profiles switch during acute exudate formation to "reprogram" the exudate PMNs to promote resolution.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prostaglandin E2 (PGE2) and D2 rapidly initiate the resolution process by inducing the expression of lipid mediators with both anti-inflammatory and pre-resolution functions, e.g., lipoxins [96, 97], resolvins and protectins [98–100], a process known as lipid-mediator class switch [97].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [97]
Citations
Cites
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Godson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N., & Brady, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1663 · Cited by 638
Inflammation: Basic Principles and Clinical Correlates
Ehrlich, G. E. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.283.1.123 · Cited by 622
Shinmura, K., Tang, X.-L., Wang, Y., Xuan, Y.-T., Liu, S.-Q., Takano, H., Bhatnagar, A., & Bolli, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10197 · Cited by 381
Swan, S. K., Rudy, D. W., Lasseter, K. C., Ryan, C. F., Buechel, K. L., Lambrecht, L. J., Pinto, M. B., Dilzer, S. C., Obrda, O., Sundblad, K. J., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00002 · Cited by 339
Design of Lipoxin A4 Stable Analogs That Block Transmigration and Adhesion of Human Neutrophils
Serhan, C. N., Maddox, J. F., Petasis, N. A., Akritopoulou-Zanze, I., Papayianni, A., Brady, H. R., Colgan, S. P., & Madara, J. L. (1995) · Biochemistry · doi:10.1021/bi00044a041 · Cited by 327
Self-citationActivation of the NF-κB Pathway by Inflammatory Stimuli in Human Neutrophils
McDonald, P. P., Bald, A., & Cassatella, M. A. (1997) · Blood · doi:10.1182/blood.v89.9.3421 · Cited by 324
Prostaglandins, Aspirin-like Drugs and the Oedema of Inflammation
MONCADA, S., FERREIRA, S. H., & VANE, J. R. (1973) · Nature · doi:10.1038/246217a0 · Cited by 312 · cited 1×
“Although PGE 2 induces reactions that mediate several of the cardinal features of inflammation (for example, edem”
BackgroundTessier, P. A., Naccache, P. H., Clark-Lewis, I., Gladue, R. P., Neote, K. S., & McColl, S. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3595 · Cited by 233
Research works printed but not linked: 2
- Light, R. W. Pleural Diseases (Lea & Febiger, Philadelphia, 1990).
- Clish, C. B. et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl Acad Sci USA 96, 8247–8252 (1999). · DOI · Paper page
Cited by
Items 201–300 of 1,000
Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles
Beck-Speier, I., Dayal, N., Karg, E., Maier, K. L., Schumann, G., Schulz, H., Semmler, M., Takenaka, S., Stettmaier, K., Bors, W., et al. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.01.004 · Cited by 167
Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease
Pirault, J., & Bäck, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01273 · Cited by 165
Fatty acid metabolism in the progression and resolution of CNS disorders
Bogie, J. F. J., Haidar, M., Kooij, G., & Hendriks, J. J. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.01.004 · Cited by 167
Rahman, M. M., Bibi, S., Rahaman, M. S., Rahman, F., Islam, F., Khan, M. S., Hasan, M. M., Parvez, A., Hossain, M. A., Maeesa, S. K., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113041 · Cited by 166
RetractedSERHAN, C. N. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03396.x · Cited by 166
Self-citationNovel Resolvin D2 Receptor Axis in Infectious Inflammation
Chiang, N., de la Rosa, X., Libreros, S., & Serhan, C. N. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601650 · Cited by 161
“, leukotriene [LT]B4) to the biosynthesis of lipoxins (LX) (7) and specialized proresolving mediators (SPM) (8–11).”
BackgroundSelf-citation12/15-Lipoxygenase Counteracts Inflammation and Tissue Damage in Arthritis
Krönke, G., Katzenbeisser, J., Uderhardt, S., Zaiss, M. M., Scholtysek, C., Schabbauer, G., Zarbock, A., Koenders, M. I., Axmann, R., Zwerina, J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900327 · Cited by 163
“Although 5-LO itself mainly contributes to the propagation of inflammation by an abundant generation of proinflammatory leukotrienes, the expression of human 15-LO and its murine homologue 12/15-LO follows the expression of 5-LO and COX-2 and shows a peak expression during the resolution phase of inflammation (32).”
BackgroundSitkovsky, M. V. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01548-4 · Cited by 164
Markworth, J. F., Vella, L., Lingard, B. S., Tull, D. L., Rupasinghe, T. W., Sinclair, A. J., Maddipati, K. R., & Cameron-Smith, D. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00128.2013 · Cited by 163
“the transcription of the 15-LOX enzyme in neutrophils, promoting a shift from LT to LX 644 biosynthesis, a phenomenon termed lipid class switching (51).”
BackgroundMoos, P. J., Edes, K., Cassidy, P., Massuda, E., & Fitzpatrick, F. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211134200 · Cited by 163
A pivotal role of cytosolic phospholipase A2 in bleomycin-induced pulmonary fibrosis
Nagase, T., Uozumi, N., Ishii, S., Kita, Y., Yamamoto, H., Ohga, E., Ouchi, Y., & Shimizu, T. (2002) · Nature Medicine · doi:10.1038/nm0502-480 · Cited by 163
Fredman, G., & Serhan, C. N. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00984-x · Cited by 186
“This process is termed ‘lipid mediator class switch’, in which the different lipid mediators are temporally produced in the inflammatory exudates, reflecting the specific cell types carrying the enzymes required to bio-synthesize each family of SPMs 18,41 .”
Self-citationn−3 Fatty acids, inflammation, and immunity— Relevance to postsurgical and critically III patients
Calder, P. C. (2004) · Lipids · doi:10.1007/s11745-004-1342-z · Cited by 159
“15-LOX so promoting the formation of lipoxins (61,62) that have”
Keep calm: the intestinal barrier at the interface of peace and war
Thoo, L., Noti, M., & Krebs, P. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2086-z · Cited by 159
NLRP3 Inflammasome Deficiency Protects against Microbial Sepsis via Increased Lipoxin B 4 Synthesis
Lee, S., Nakahira, K., Dalli, J., Siempos, I. I., Norris, P. C., Colas, R. A., Moon, J.-S., Shinohara, M., Hisata, S., Howrylak, J. A., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0892oc · Cited by 156
“During the onset of the resolution phase, eicosanoid class switching occurs through changes in production within the arachidonate-derived family, for example, in lipoxins (LXs) (12).”
BackgroundSelf-citationGiannakis, N., Sansbury, B. E., Patsalos, A., Hays, T. T., Riley, C. O., Han, X., Spite, M., & Nagy, L. (2019) · Nature Immunology · doi:10.1038/s41590-019-0356-7 · Cited by 157
Role of Se-dependent glutathione peroxidases in gastrointestinal inflammation and cancer
Chu, F., Esworthy, R. S., & Doroshow, J. H. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.010 · Cited by 178
Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome
Werner, M., Jordan, P. M., Romp, E., Czapka, A., Rao, Z., Kretzer, C., Koeberle, A., Garscha, U., Pace, S., Claesson, H., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802509r · Cited by 156
“LMs produced via the COX-1/2 pathway display proinflammatorybut alsoprotective actionsdependingon stimulus, cell type, and status that program the ability to resolve inflammation (5, 38).”
BackgroundSelf-citationNutrition and human health from a sex–gender perspective
Marino, M., Masella, R., Bulzomi, P., Campesi, I., Malorni, W., & Franconi, F. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.02.001 · Cited by 175
“Resolvins, lipoxins, protectins and maresins are endogenous local acting mediators that possess potent anti-inflammatory and immunoregulatory properties (Ariel and Serhan, 2007; Bandeira-Melo et al., 2000; Chiang et al., 1999; Claria and Serhan, 1995; Levy et al., 2001; Levy et al., 2007a).”
BackgroundMacrophages in gastrointestinal homeostasis and inflammation
Grainger, J. R., Konkel, J. E., Zangerle-Murray, T., & Shaw, T. N. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1958-2 · Cited by 175
“For example, in resolving inflammatory exudates, it has been suggested that PGE2 and PGD2 can stimulate production of a functional enzyme for lipoxin in neutrophils [57].”
Infection and inflammatory mechanisms
Dyke, T. E. V., & Winkelhoff, A. J. V. (2013) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12088 · Cited by 188
Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound
Vachier, I., Bonnans, C., Chavis, C., Farce, M., Godard, P., Bousquet, J. J., & Chanez, P. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.09.038 · Cited by 161
Fang, X., Abbott, J., Cheng, L., Colby, J. K., Lee, J. W., Levy, B. D., & Matthay, M. A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500244 · Cited by 153
“LXA4 was the first identified anti-inflammatory and proresolving lipid mediator (14, 16).”
BackgroundSelf-citationLukashev, D., Ohta, A., Apasov, S., Chen, J.-F., & Sitkovsky, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.21 · Cited by 153
Phospholipase A2regulates eicosanoid class switching during inflammasome activation
Norris, P. C., Gosselin, D., Reichart, D., Glass, C. K., & Dennis, E. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404372111 · Cited by 151
“Whereas PGE2, PGI2, and LTC4 promote local edema from postcapillary venules, and LTB4 amplifies neutrophil recruitment to initiate pathogenic killing, subsequent “class switching” to lipoxin (LX) formation by “reprogrammed” neutrophils inhibits additional neutrophil recruitment during self-resolving inflammatory resol…”
BackgroundHost persistence: exploitation of anti-inflammatory pathways by Toxoplasma GONDII
Aliberti, J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1547 · Cited by 182
Recchiuti, A., & Serhan, C. N. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00298 · Cited by 149
“Blood vessels”
BackgroundResultSelf-citationMaier, K., Alessandrini, F., Beck‐Speier, I., Hofer, T. P. J., Diabaté, S., Bitterle, E., Stöger, T., Jakob, T., Behrendt, H., Horsch, M., et al. (2008) · Inhalation Toxicology · doi:10.1080/08958370701866313 · Cited by 171
“One important function of prostaglandin (PG) E2 is its capability to trigger switching from proinflammatory to antiinflammatory mechanisms, which precludes activation of the 15-lipoxygenase pathway and formation of lipoxins as stop signals of inflammation (Levy et al., 2001).”
BackgroundElajami, T. K., Colas, R. A., Dalli, J., Chiang, N., Serhan, C. N., & Welty, F. K. (2016) · The FASEB Journal · doi:10.1096/fj.201500155r · Cited by 143
“resolvins, protectins and maresins [(6); reviewed in Serhan (7)].”
BackgroundSelf-citationBang, S., Yoo, S., Yang, T., Cho, H., & Hwang, S. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01568.x · Cited by 148
“mostly composed of w-6-derived mediators, and by contrast, w-3-derived mediators contribute to the resolution of inflammation in the late stage (Levy et al., 2001).”
BackgroundLipoxins: endogenous regulators of inflammation
McMahon, B., & Godson, C. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00224.2003 · Cited by 148
“Injection of TNF- into the pouch cavity led to a rapid increase in LTB4 that preceded infiltration of PMN (70).”
BackgroundInfluentialSilva, M. T. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0910536 · Cited by 147
“pro-resolving factors [10, 113], suggesting autocrine stimula-”
N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation
Joffre, C., Rey, C., & Layé, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01022 · Cited by 147
Calder, P. C. (2020) · Biochimie · doi:10.1016/j.biochi.2020.08.015 · Cited by 165
“Amongst the most important SPMs are lipoxin A 4 generated from arachidonic acid [5-7] and a series of mediators generated from the omega-3 (n-3) polyunsaturated fatty acids (PUFAs) eicosapentaenoic, docosapentaenoic and docosahexaenoic acid [8-11].”
Maksymowych, W. P., Wichuk, S. A., Chiowchanwisawakit, P., Lambert, R. G. W., & Pedersen, S. J. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38792 · Cited by 149
“, PGE2 and PGD2) and leukotrienes are involved in the initiation and amplification of acute inflammation, PGE2 and PGD2 stimulate a switch of arachidonic acid–derived lipids from leukotriene to lipoxin production through activation of 15-lipoxygenase (28).”
BackgroundEosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice
Yamada, T., Tani, Y., Nakanishi, H., Taguchi, R., Arita, M., & Arai, H. (2011) · The FASEB Journal · doi:10.1096/fj.10-170027 · Cited by 143
Hammock, B. D., Wang, W., Gilligan, M. M., & Panigrahy, D. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.06.010 · Cited by 160
Gilroy, D. W., Colville‐Nash, P., McMaster, S. K., Sawatzky, D. A., Willoughby, D. A., & Lawrence, T. (2003) · The FASEB Journal · doi:10.1096/fj.02-1162fje · Cited by 164
“So far lipoxins, a family of naturally occurring lipid mediators originally described to possess potent suppressive effects on leukocyte function (24), have been shown to be formed concurrently with spontaneous resolution in both clinical and experimental samples, where they aid resolution by switching off inflammator…”
BackgroundBannenberg, G., Moussignac, R., Gronert, K., Devchand, P. R., Schmidt, B. A., Guilford, W. J., Bauman, J. G., Subramanyam, B., Daniel Perez, H., Parkinson, J. F., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705912 · Cited by 138
“Endogenous formation of LX occurs during inflamma- tion, both in man and in animal models (Edenius et al., 1990; Lee et al., 1990; Levy et al., 2001)).”
BackgroundSelf-citationDalli, J., & Serhan, C. N. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14336 · Cited by 138
“These PGs are important in up-regulating the expression of 15-lipoxygenase type 1 (15-LOX-1), the initiating enzyme in the lipoxin biosynthetic pathway (Levy et al., 2001).”
BackgroundSelf-citationSouza, D. G., Fagundes, C. T., Amaral, F. A., Cisalpino, D., Sousa, L. P., Vieira, A. T., Pinho, V., Nicoli, J. R., Vieira, L. Q., Fierro, I. M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8533 · Cited by 138
“There are evidences that acute inflammation resolution involve temporal regulation of lipid mediator generation, with early coordinate appearance of leukotrienes and prostaglandins followed by lipoxin production in the next phase of the inflammatory response (61).”
BackgroundMiki, Y., Yamamoto, K., Taketomi, Y., Sato, H., Shimo, K., Kobayashi, T., Ishikawa, Y., Ishii, T., Nakanishi, H., Ikeda, K., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121887 · Cited by 138
“During the process of inflammation, lipid mediator profiles switch from proinflammatory to antiinflammatory products, which in turn contribute to sequestration of the recruitment of inflammatory cells to the site (Levy et al., 2001; Serhan et al., 2008).”
Poorani, R., Bhatt, A. N., Dwarakanath, B. S. R., & Das, U. N. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.049 · Cited by 149
Neutrophil Development, Migration, and Function in Teleost Fish
Havixbeck, J. J., & Barreda, D. R. (2015) · Biology · doi:10.3390/biology4040715 · Cited by 163
“Mammalian research has now shown that neutrophils alter their phenotype to produce different lipid mediator profiles depending on the environmental milieu [105,107].”
BackgroundDysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma
Miyata, J., Fukunaga, K., Iwamoto, R., Isobe, Y., Niimi, K., Takamiya, R., Takihara, T., Tomomatsu, K., Suzuki, Y., Oguma, T., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.048 · Cited by 136
Can Early Omega-3 Fatty Acid Exposure Reduce Risk of Childhood Allergic Disease?
Miles, E., & Calder, P. (2017) · Nutrients · doi:10.3390/nu9070784 · Cited by 133
“For example, PGE2 inhibits 5‐LOX activity so 131 down‐regulating LT production [28].”
Is there a role for fatty acids in early life programming of the immune system?
Calder, P. C., Kremmyda, L.-S., Vlachava, M., Noakes, P. S., & Miles, E. A. (2010) · Proceedings of The Nutrition Society · doi:10.1017/s0029665110001552 · Cited by 149
“PGE2 inhibits 5-LOX activity, so down-regulating LT production((25)).”
Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases
Panigrahy, D., Gartung, A., Yang, J., Yang, H., Gilligan, M. M., Sulciner, M. L., Bhasin, S. S., Bielenberg, D. R., Chang, J., Schmidt, B. A., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127282 · Cited by 132
“Specifically, tight regulation of the temporal pattern of PGE2 release is critical for activating the class switching of lipid mediators from production of inflammatory mediators to that of proresolution signals through specialized proresolving mediators (SPMs) (40, 41).”
BackgroundSelf-citationPark, J., Langmead, C. J., & Riddy, D. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00075 · Cited by 143
New insights into the resolution of inflammation
Gilroy, D. W., & Maeyer, R. P. H. D. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.05.003 · Cited by 156
Mediator lipidomics in acute inflammation and resolution
Arita, M. (2012) · Journal of Biochemistry · doi:10.1093/jb/mvs092 · Cited by 131
Diversity of lipid mediators in human adipose tissue depots
Clària, J., Nguyen, B. T., Madenci, A. L., Ozaki, C. K., & Serhan, C. N. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00351.2012 · Cited by 130
“, prostaglandins (PGs) PGE2 and PGD2] also signal the end by stimulating the local production of SPM that actively stimulate resolution mechanisms (17).”
Self-citationHuman milk proresolving mediators stimulate resolution of acute inflammation
Arnardottir, H., Orr, S. K., Dalli, J., & Serhan, C. N. (2016) · Mucosal Immunology · doi:10.1038/mi.2015.99 · Cited by 131
“2), consisting primarily of PGE 2 and PGD 2 (~81.5% of total prostanoids) that are key in LM mediator class switching and initiation of resolution 16 .”
BackgroundInfluentialSelf-citationLipoxin A4 Regulates Bronchial Epithelial Cell Responses to Acid Injury
Bonnans, C., Fukunaga, K., Levy, M. A., & Levy, B. D. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051056 · Cited by 142
“PGE2 induces airway epithelial cell wound closure(18) and can switch PMN phenotype from proinflammatory effector to generator of anti-inflammatory signals.(12,15) During experimental acid-induced acute lung injury, decreasing COX-2 activity by pharmacological inhibition or gene disruption markedly increases PMN infilt…”
BackgroundSelf-citationNSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase
Kolawole, O. R., & Kashfi, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031432 · Cited by 148
“Intercellular interactions between the lipoxygenase enzymes in PMNs recruited to the injury site and in inflamed tissue cells result in the switch in the synthesis of LTs to the generation of pro-resolving mediators, thereby enhancing resolution mechanisms [308].”
BackgroundWada, K., Arita, M., Nakajima, A., Katayama, K., Kudo, C., Kamisaki, Y., & Serhan, C. N. (2006) · The FASEB Journal · doi:10.1096/fj.06-5809com · Cited by 130
“evoke opposing responses, including LXA4 inhibition of LTB4-induced chemotaxis, adhesion, transmigration, and superoxide anion generation in PMN in vitro and in vivo (19, 20).”
BackgroundSelf-citationFPR2/ALXR Agonists and the Resolution of Inflammation
Corminboeuf, O., & Leroy, X. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501051x · Cited by 139
Immunometabolism during Mycobacterium tuberculosis Infection
Howard, N. C., & Khader, S. A. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.04.010 · Cited by 148
“PGE2 is balanced by lipoxins such as lipoxin A4 (LXA4), which have anti-inflammatory effects [105] (Figure 2).”
BackgroundResolving an inflammatory concept: The importance of inflammation and resolution in tendinopathy
Dakin, S. G., Dudhia, J., & Smith, R. K. W. (2014) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2014.01.007 · Cited by 133
N-3 polyunsaturated fatty acids and allergic disease
Prescott, S. L., & Calder, P. C. (2004) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200403000-00004 · Cited by 128
Flamand, N., Surette, M. E., Picard, S., Bourgoin, S. G., & Borgeat, P. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.250 · Cited by 128
“…formation of an anti-inflammatory lipid mediator such as lipoxin A4 would strengthen the anti-inflammatory signals triggered by autacoids such as adenosine (Cronstein, 1994; Ohta and Sitkovsky, 2001) and contribute to the down-regulation and/or resolution of inflammation (Levy et al., 2001).”
BackgroundArachidonic acid in health and disease with focus on hypertension and diabetes mellitus: A review
Das, U. N. (2018) · Journal of Advanced Research · doi:10.1016/j.jare.2018.01.002 · Cited by 138
Li, Y., Dalli, J., Chiang, N., Baron, R. M., Quintana, C., & Serhan, C. N. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.011 · Cited by 126
“Given that in these experimental settings PMNs did not express 12/ 15-LOX, the murine ortholog of human 15-LOX-1 (Levy et al., 2001), these results suggest that miR-466l expression in macrophages promotes RvD1 biosynthesis, which in turn regulates exudate dissolution.”
InfluentialSelf-citationLipid metabolism and endometrial receptivity
Yang, T., Zhao, J., Liu, F., & Li, Y. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac026 · Cited by 151
Fatty acids and lipid mediators in inflammatory bowel disease: from mechanism to treatment
Yan, D., Ye, S., He, Y., Wang, S., Xiao, Y., Xiang, X., Deng, M., Luo, W., Chen, X., & Wang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1286667 · Cited by 146
“PGs serve as key regulators of vascular responses, modulating in fl ammatory cell in fi ltration (187).”
BackgroundPrieto, P., Cuenca, J., Través, P. G., Fernández‐Velasco, M., Martín‐Sanz, P., & Boscá, L. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2009.220 · Cited by 132
“Regulation of apoptosis of immune cells is a critical stage during inflammation because when the injury is over, accomplishment of a correct resolution, mainly through apoptotic death, prevents the development of chronic inflammatory diseases.(1,2) During this process, neutrophils are quickly recruited to sites of inf…”
BackgroundKoeberle, A., & Werz, O. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.022 · Cited by 124
García-Alonso, V., Titos, E., Alcaraz-Quiles, J., Rius, B., Lopategi, A., López-Vicario, C., Jakobsson, P.-J., Delgado, S., Lozano, J., & Clària, J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153751 · Cited by 123
“The ability of PGE2 to promote tissue host self-preservation has been documented to be mediated by the increase in the levels of the intracellular second messenger cAMP [28].”
BackgroundTargeting Neutrophils for Promoting the Resolution of Inflammation
Filep, J. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.866747 · Cited by 142
Gomez, G., & Sitkovsky, M. V. (2003) · Blood · doi:10.1182/blood-2002-11-3624 · Cited by 124
Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa
Boer, J., & Jemec, G. B. E. (2009) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2009.03377.x · Cited by 123
Nadtochiy, S. M., & Redman, E. K. (2011) · Nutrition · doi:10.1016/j.nut.2010.12.006 · Cited by 122
“Biosynthesis of these molecules is achieved by 15-lypoxygenase at the moment of inflammation, with ensuing regulation of PMN infiltration into the tissue [127].”
BackgroundTaketomi, Y., Ueno, N., Kojima, T., Sato, H., Murase, R., Yamamoto, K., Tanaka, S., Sakanaka, M., Nakamura, M., Nishito, Y., et al. (2013) · Nature Immunology · doi:10.1038/ni.2586 · Cited by 122
Macrophage Proresolving Mediators—the When and Where
Dalli, J., & Serhan, C. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0001-2014 · Cited by 121
“…fi c signaling is dictated by speci fi c G protein coupling, which is cell type speci fi c. PGE 2 has anti-in fl ammatory actions such as stopping neutrophil migration, as does PGD 2 , but these mediators have a distinction in that they can induce the apparatus responsible for lipoxin production (15).”
BackgroundSelf-citationModulation of Neutrophil Apoptosis and the Resolution of Inflammation through β2 Integrins
El Kebir, D., & Filep, J. G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00060 · Cited by 121
“Accumulation of PGE2 at inflammatory sites induces a lipid mediator class switching from a predominantly 5-lipoxygenase activity to a 15lipoxygenase activity generating LXA4 parallel with the resolution of inflammation (Levy et al., 2001) Thus, initiation of an inflammatory response would also activate subsequent pro-…”
BackgroundUnderstanding dental pulp inflammation: from signaling to structure
Pohl, S., Akamp, T., Smeda, M., Uderhardt, S., Besold, D., Krastl, G., Galler, K. M., Buchalla, W., & Widbiller, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1474466 · Cited by 156
Cyclooxygenase‐2 deficient mice are resistant to endotoxin‐induced inflammation and death
江島, 邦., Layne, M. D., Carvajal, I. M., Kritek, P., Baron, R. M., Chen, Y., Saal, J. V., Levy, B. D., Yet, S., & Perrella, M. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-1078fje · Cited by 131
“Thromboxane (Tx)B2 and prostaglandin (PG)E2 were measured from tissue extracts using ELISA kits as described previously (22).”
MethodSelf-citationGartung, A., Yang, J., Sukhatme, V. P., Bielenberg, D. R., Fernandes, D., Chang, J., Schmidt, B. A., Hwang, S. H., Zurakowski, D., Huang, S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803999116 · Cited by 119
“Our findings are consistent with reports that PGE2 promotes lipid mediator class switching to stimulate resolution (48) and that it can act as a damageassociated molecular pattern in therapy-induced dead tumor cells to regulate inflammation (49).”
ResultSelf-citationNatto, Z. S., Yaghmoor, W., Alshaeri, H. K., & Van Dyke, T. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-54535-x · Cited by 119
Serhan, C. N. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.080231 · Cited by 132
Self-citationThe role of COX-2 and Nrf2/ARE in anti-inflammation and antioxidative stress: Aging and anti-aging
Luo, C., Urgard, E., Vooder, T., & Metspalu, A. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.04.002 · Cited by 131
“switch to an anti-inflammatory response [22].”
Voiriot, G., Philippot, Q., Elabbadi, A., Elbim, C., Chalumeau, M., & Fartoukh, M. S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060786 · Cited by 128
“It has been demonstrated that first-phase COX-2-induced eicosanoids promote a shift to anti-inflammatory lipids, which deliver a stop signal [33,34].”
BackgroundMacrophage development and polarization in chronic inflammation
Motwani, M. P., & Gilroy, D. W. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.07.002 · Cited by 129
Rhodes, L. E., Gledhill, K., Masoodi, M., Haylett, A. K., Brownrigg, M., Thody, A. J., Tobin, D. J., & Nicolaou, A. (2009) · The FASEB Journal · doi:10.1096/fj.09-136077 · Cited by 118
Dying to Live: How the Death Modality of the Infected Macrophage Affects Immunity to Tuberculosis
Divangahi, M., Behar, S. M., & Remold, H. G. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-6111-1_6 · Cited by 130
“different enzymes including 5- and 15-lipoxygenases [51].”
An overview of the biologic effects of omega-6 oxylipins in humans
Shearer, G. C., & Walker, R. E. (2018) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.06.005 · Cited by 122
Menschikowski, M., Hagelgans, A., & Siegert, G. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2005.10.005 · Cited by 127
Isobe, Y., Kato, T., & Arita, M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00270 · Cited by 127
“In inflammatory exudates, lipid mediators change in the course of acute inflammation and resolution (Levy et al., 2001; Bannenberg et al., 2005; Blaho et al., 2009; Yamada et al., 2011).”
BackgroundFattori, V., Pinho-Ribeiro, F. A., Staurengo‐Ferrari, L., Borghi, S. M., Rossaneis, A. C., Casagrande, R., & Verri, W. A., Jr. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14647 · Cited by 121
Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke
Capra, V., Bäck, M., Barbieri, S. S., Camera, M., Tremoli, E., & Rovati, G. E. (2013) · Medicinal Research Reviews · doi:10.1002/med.21251 · Cited by 113
Damazo, A. S., Yona, S., Flower, R. J., Perretti, M., & Oliani, S. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4410 · Cited by 114
“To this end, endogenous pathways operate in the host and act at different phases of the leukocyte extravasation process to counteract the action of proinflammatory mediators (7, 8).”
López‐Vicario, C., Rius, B., Alcaraz‐Quiles, J., García‐Alonso, V., Lopategi, A., Titos, E., & Clària, J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.092 · Cited by 127
“…eicosanoids such as prostaglandin E2 and prostaglandin D2 initiate a switch in the class of lipid mediators, by which endogenous circuits modulate leukocyte responses in such a way that they promote the activation of enzymes required to produce pro-resolving lipid mediators (Levy et al., 2001).”
BackgroundUriarte, S. M., Edmisson, J. S., & Jimenez‐Flores, E. (2016) · Immunological Reviews · doi:10.1111/imr.12451 · Cited by 112
Hansen, T. V., Vik, A., & Serhan, C. N. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01582 · Cited by 123
Self-citation15-Deoxy-Δ12,1412,14-prostaglandins D2 and J2 Are Potent Activators of Human Eosinophils
Monneret, G., Li, H., Vasilescu, J., Rokach, J., & Powell, W. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3563 · Cited by 112
“In contrast, most of the eicosanoids formed by the 5-lipoxygenase pathway, including leukotriene B4, the cysteinyl-leukotrienes, and 5-oxoETE, appear to have strictly proinflammatory effects (46), with the exception of the lipoxins, which are highly potent antiinflammatory agents at nanomolar or subnanomolar concentra…”
BackgroundTowards targeting resolution pathways of airway inflammation in asthma
Barnig, C., Frossard, N., & Levy, B. D. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.004 · Cited by 121
Self-citationHyvärinen, K., Holopainen, M., Skirdenko, V., Ruhanen, H., Lehenkari, P., Korhonen, M., Käkelä, R., Laitinen, S., & Kerkelä, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00771 · Cited by 111
Metabolomics in rheumatoid arthritis: Advances and review
Xu, L., Chang, C., Jiang, P., Wei, K., Zhang, R., Jin, Y., Zhao, J., Xu, L., Shi, Y., Guo, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.961708 · Cited by 133
Beneficial effects of n-3 PUFA on chronic airway inflammatory diseases
Giudetti, A. M., & Cagnazzo, R. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.09.006 · Cited by 109
“Some AA-derived eicosanoids, such as PGE2, have both proand anti-inflammatory roles [48–50].”
BackgroundResolvins: Natural agonists for resolution of pulmonary inflammation
Uddin, M., & Levy, B. D. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.09.002 · Cited by 126
“During acute inflammation, early phase prostaglandin (PG) E2 and PGD2 can decrease neutrophil leukotriene (LT) generation and increase expression of 15lipoxygenase (15-LOX) to switch LOX-derived AA metabolism to the biosynthesis of lipoxins [16], which are stop signals for neutrophil transmigration and activation, as…”
BackgroundSelf-citation
Metadata
- Authors
- Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Serhan, Charles N.
- Venue
- Nature Immunology
- Published
- 2001-07
- Volume
- 2
- Issue
- 7
- Pages
- 612-619
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1497700962
- Cited by
- 1,453
- References
- 42
- Citations by year
- 2026: 48 · 2025: 60 · 2024: 61 · 2023: 74 · 2022: 74 · 2021: 81 · 2020: 76 · 2019: 64 · 2018: 69 · 2017: 62 · 2016: 62 · 2015: 63 · 2014: 62 · 2013: 69 · 2012: 60
- FWCI
- 33.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k08hl003788-04)
- National Heart, Lung, and Blood Institute (K08 HL 03788)
- National Institute of General Medical Sciences (GM 38765)
- National Institute of Allergy and Infectious Diseases (F32AI010389, F32-AI10389)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-50305, P01DK050305, K01DK060583)
- National Institute of Dental and Craniofacial Research (P01 DE 13499, P01DE013499)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- lipid mediators, acute inflammation, inflammation resolution, leukotrienes, prostaglandins, lipoxins, eicosanoid biosynthesis, neutrophil recruitment, lipoxin A4, leukotriene B4, 5-lipoxygenase, 15-lipoxygenase, prostaglandin E2, exudate, anti-inflammatory signaling
- MeSH terms
- Animals, Arachidonate 15-Lipoxygenase, Base Sequence, Humans, Hydroxyeicosatetraenoic Acids, Leukotriene B4, Lipids, Male, Mice, Inbred BALB C, Molecular Sequence Data, Neutrophils, Pleural Effusion, RNA, Messenger, Dinoprostone, Molecular Structure, Signal Transduction, DNA, Complementary, Lipoxins, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.